Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ani Pharmaceuticals (ANIP) Cash from Financing Activities (2016 - 2025)

Ani Pharmaceuticals (ANIP) has disclosed Cash from Financing Activities for 16 consecutive years, with -$4.6 million as the latest value for Q4 2025.

  • Quarterly Cash from Financing Activities rose 5.52% to -$4.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$9.9 million through Dec 2025, down 103.75% year-over-year, with the annual reading at -$9.9 million for FY2025, 103.75% down from the prior year.
  • Cash from Financing Activities hit -$4.6 million in Q4 2025 for Ani Pharmaceuticals, down from $6.3 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $291.0 million in Q3 2024 to a low of -$19.7 million in Q1 2024.
  • Historically, Cash from Financing Activities has averaged $25.6 million across 5 years, with a median of -$1.6 million in 2024.
  • Biggest five-year swings in Cash from Financing Activities: soared 8226.99% in 2021 and later crashed 2246.06% in 2023.
  • Year by year, Cash from Financing Activities stood at $179.4 million in 2021, then tumbled by 100.28% to -$508000.0 in 2022, then plummeted by 2246.06% to -$11.9 million in 2023, then surged by 58.83% to -$4.9 million in 2024, then increased by 5.52% to -$4.6 million in 2025.
  • Business Quant data shows Cash from Financing Activities for ANIP at -$4.6 million in Q4 2025, $6.3 million in Q3 2025, and -$1.7 million in Q2 2025.